As one of the oldest infectious diseases, human beings are still suffering from tuberculosis. This March 24th is the twenty-seventh "World TB Day". The theme of China's propaganda is "life first, action by the whole people, sharing health and ending TB". The social media research center of Peking University recently held an online seminar on "coordinating multiple forces to reduce the burden for tuberculosis patients". Experts say tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis (TB), also known as "tuberculosis". Tuberculosis can occur in any part of the body except hair and nails. More than 80% of these diseases are tuberculosis in the lungs, trachea, bronchi and pleura. The rest are collectively referred to as extrapulmonary tuberculosis. Tuberculosis is mainly transmitted through the respiratory tract. Tuberculosis patients can spread Mycobacterium tuberculosis into the air when they cough, expectoration and sneeze. Healthy people inhaled with the droplets of Mycobacterium tuberculosis may be infected. Generally speaking, in case of suspicious symptoms of pulmonary tuberculosis such as cough, expectoration for more than 2 weeks or blood in sputum, timely treatment is required to avoid delaying the condition. Can tuberculosis be cured? Experts pointed out that most patients with ordinary pulmonary tuberculosis can be cured after receiving standardized anti tuberculosis treatment for 6-8 months. If the treatment is not standardized, it may lead to treatment failure and even become drug-resistant tuberculosis. The course of treatment of drug-resistant pulmonary tuberculosis takes 18-24 months, with high incidence of adverse reactions, low cure rate and high mortality. The medical cost is nearly 100 times that of ordinary pulmonary tuberculosis. As a high burden country for TB, China has invested a lot in the prevention and control of tuberculosis. Experts say that China's basic medical insurance coverage is very high. Medical insurance basically covers TB patients and has a tilt policy towards TB. Mao Zongfu, Professor of the school of public health, Wuhan University, said that the state's key transfer payments to the key areas of tuberculosis, expanding the scope of medical insurance directory, through drug negotiations and centralized procurement with quantity have further reduced the burden on patients. Tuberculosis is a chronic consumptive disease. Patients should pay attention to dietary nutrition, and should pay more attention to rest and avoid fatigue. According to experts, even if some patients with poor families enjoy free diagnosis and treatment, the transportation, accommodation and other expenses caused by treatment are still a heavy burden for them. For such patients, the reduction of medical expenses is not enough. There should also be a corresponding social security mechanism to ensure that they complete the whole course of treatment. Therefore, we should further promote multi-channel financing, focus on the actual needs of patients, and improve the level of social security for patients. Chen Jiaying, director of the humanities and Management Department of Kangda college, Nanjing Medical University, believes that in the treatment and prevention and control of tuberculosis, we should play a multifaceted role, especially in the role of medical insurance in encouraging hospitals to take the initiative to carry out preventive work. In Mao Zongfu's view, there are two key links that affect the burden of TB patients. One is how to reduce the financial burden of the poor, so that they can cure the disease. The second is to implement standardized and quality treatment, which is the key link of reducing burden and increasing efficiency. In this regard, Mao Zongfu suggested that we should advocate universal participation and form a social consensus, and prevention is the most economic means. On the basis of social consensus, we should form social joint forces through multi-party linkage, strive for early detection, early diagnosis and early treatment, and change from passive to active, so that patients can receive high-quality and standardized treatment in time, strive to shorten the cure cycle and improve the cure rate; We will continue to increase financial input and research investment in comprehensive prevention and control of tuberculosis, improve the guidelines for comprehensive prevention and control, strengthen the supervision of medical insurance funds and clinical quality, and improve the quality of diagnosis and treatment. (outlook new era)